CAMPISI, RAFFAELE
 Distribuzione geografica
Continente #
NA - Nord America 833
AS - Asia 776
EU - Europa 576
AF - Africa 129
SA - Sud America 79
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.395
Nazione #
US - Stati Uniti d'America 808
SG - Singapore 329
CN - Cina 301
RU - Federazione Russa 297
IT - Italia 181
CI - Costa d'Avorio 81
KR - Corea 75
BR - Brasile 72
IE - Irlanda 30
SN - Senegal 23
IN - India 21
VN - Vietnam 19
GB - Regno Unito 18
CA - Canada 16
FI - Finlandia 14
NL - Olanda 11
BJ - Benin 10
ZA - Sudafrica 7
DE - Germania 5
HK - Hong Kong 5
JP - Giappone 5
MX - Messico 5
PL - Polonia 5
SE - Svezia 5
AR - Argentina 4
ES - Italia 4
IQ - Iraq 4
KE - Kenya 4
BD - Bangladesh 3
AE - Emirati Arabi Uniti 2
FR - Francia 2
IL - Israele 2
IR - Iran 2
LT - Lituania 2
MA - Marocco 2
PH - Filippine 2
TR - Turchia 2
VE - Venezuela 2
AT - Austria 1
AU - Australia 1
BB - Barbados 1
CR - Costa Rica 1
EC - Ecuador 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 2.395
Città #
Singapore 217
Santa Clara 198
Dallas 187
Hefei 166
Moscow 123
Abidjan 81
Seoul 74
Ashburn 58
Chicago 53
Los Angeles 44
Beijing 35
Civitanova Marche 34
Boardman 32
Dublin 30
Dakar 23
Catania 19
Milan 17
Zafferana Etnea 15
Chandler 11
Buffalo 10
Cotonou 10
New York 10
Lappeenranta 9
Ho Chi Minh City 8
Montreal 8
Palermo 8
Kochi 7
Rome 7
Amsterdam 6
Giarre 6
Orem 6
São Paulo 6
Chennai 5
Johannesburg 5
Phoenix 5
Pune 5
Stockholm 5
Tokyo 5
Warsaw 5
Bari 4
Brooklyn 4
Helsinki 4
Manchester 4
Munich 4
Toronto 4
Treviso 4
Boydton 3
Charlotte 3
Council Bluffs 3
Hanoi 3
Hong Kong 3
Madrid 3
Mascalucia 3
Praia Grande 3
Seattle 3
Abbiategrasso 2
Ankara 2
Astoria 2
Baghdad 2
Bitonto 2
Cagliari 2
Cesa 2
Corato 2
Denver 2
Dong Ket 2
Fortaleza 2
Giulianova 2
Houston 2
Laives 2
Legnano 2
London 2
Pittsburgh 2
Poplar 2
Querétaro 2
Quảng Ngãi 2
Reggio Emilia 2
Ribeirão das Neves 2
Rimini 2
Rio de Janeiro 2
Salvador 2
San Francisco 2
San Giovanni in Persiceto 2
Sorocaba 2
São Bernardo do Campo 2
Tai Wan 2
Tehran 2
Turin 2
Washington 2
Alexandria 1
Almirante Tamandaré 1
Amherstburg 1
Andover 1
Angra dos Reis 1
Annapolis 1
Aparecida de Goiânia 1
Aracati 1
Araras 1
Atlanta 1
Awasa 1
Balsas 1
Totale 1.686
Nome #
Female Sex Affects Respiratory Function and Exercise Ability in Patients Recovered from COVID-19 Pneumonia 143
Acute and long-term management of severe bronchiectasis with high flow nasal therapy: A case report 117
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 117
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 109
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study 105
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial 102
Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study 101
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study 100
Type 2-High Severe Asthma with and without Bronchiectasis: A Prospective Observational Multicentre Study 97
Utility of ultrasound assessment of diaphragmatic function before and after pulmonary rehabilitation in COPD patients 96
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 94
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study 90
Insuline resistance and insuline sensibility in patients with obstructive sleep apnea 84
Diagnostic delay in bronchiectasis: an Italian perspective 84
Impact of asthma on bronchiectasis severity and risk of exacerbations 82
Personalized Medicine in Asthma: Current Approach and Future Perspectives 81
Better outcomes for everybody evaluates the effectiveness and cost-effectiveness of a pharmacist-led intervention, delivered by community pharmacists in collaboration with physicians, in improving disease control, compared with usual care, in asthma and COPD patients during and after COVID-19 79
Eosinophilic Bronchiectasis: Prevalence, Severity, and Associated Features—A Cohort Study 77
Sleep quality and mental health during the COVID-19 pandemic in patients with severe obstructive sleep apnea 77
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis 76
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 75
Long-Term High-Flow Nasal Therapy in Patients with Bronchiectasis of Different Severity: A Retrospective Cohort Study 73
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis 70
Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy 69
Comparability of asthma control test scores between self and physician-administered test 65
Tezepelumab for asthma 65
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program 58
Switching Biological Therapies in Severe Asthma 44
Totale 2.430
Categoria #
all - tutte 8.263
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.263


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 1 0 0 0 0 0 2
2021/20225 0 1 0 0 1 0 1 0 0 0 0 2
2022/2023148 1 0 1 4 4 2 53 40 22 10 2 9
2023/2024232 7 32 23 16 9 53 4 27 2 5 43 11
2024/2025756 11 101 56 40 147 109 30 17 20 52 86 87
2025/20261.281 127 226 248 111 238 331 0 0 0 0 0 0
Totale 2.430